| The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia J Backes, D Anzalone, D Hilleman, J Catini Lipids in Health and Disease 15, 1-12, 2016 | 224 | 2016 |
| Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance JM Backes, CV Venero, CA Gibson, JF Ruisinger, PA Howard, ... Annals of Pharmacotherapy 42 (3), 341-346, 2008 | 153 | 2008 |
| Role of C-reactive protein in cardiovascular disease JM Backes, PA Howard, PM Moriarty Annals of Pharmacotherapy 38 (1), 110-118, 2004 | 143 | 2004 |
| Association of HMG-CoA reductase inhibitors with neuropathy JM Backes, PA Howard Annals of Pharmacotherapy 37 (2), 274-278, 2003 | 92 | 2003 |
| Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intolerance JF Ruisinger, JM Backes, CA Gibson, PM Moriarty The American journal of cardiology 103 (3), 393-394, 2009 | 87 | 2009 |
| Fibrates: what have we learned in the past 40 years? JM Backes, CA Gibson, JF Ruisinger, PM Moriarty Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (3 …, 2007 | 87 | 2007 |
| Quality of diabetes care for adults with developmental disabilities TI Shireman, A Reichard, N Nazir, JM Backes, KA Greiner Disability and health journal 3 (3), 179-185, 2010 | 86 | 2010 |
| Statin-associated muscle symptoms—managing the highly intolerant JM Backes, JF Ruisinger, CA Gibson, PM Moriarty Journal of clinical lipidology 11 (1), 24-33, 2017 | 78 | 2017 |
| Effects of once weekly rosuvastatin among patients with a prior statin intolerance JM Backes, PM Moriarty, JF Ruisinger, CA Gibson The American journal of cardiology 100 (3), 554-555, 2007 | 75 | 2007 |
| Does simvastatin cause more myotoxicity compared with other statins? JM Backes, PA Howard, JF Ruisinger, PM Moriarty Annals of Pharmacotherapy 43 (12), 2012-2020, 2009 | 60 | 2009 |
| Optimal lipid modification: the rationale for combination therapy JM Backes, CA Gibson, PA Howard Vascular health and risk management 1 (4), 317-331, 2005 | 51 | 2005 |
| Effect of lipid-lowering drug therapy on small-dense low-density lipoprotein JM Backes, CA Gibson Annals of Pharmacotherapy 39 (3), 523-526, 2005 | 51 | 2005 |
| Statins and almonds to lower lipoproteins (the STALL Study) JF Ruisinger, CA Gibson, JM Backes, BK Smith, DK Sullivan, PM Moriarty, ... Journal of clinical lipidology 9 (1), 58-64, 2015 | 49 | 2015 |
| Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart disease KA Packard, JM Backes, TL Lenz, RL Wurdeman, CJ Destache, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 22 (12 …, 2002 | 38 | 2002 |
| Krill oil for cardiovascular risk prevention: is it for real? JM Backes, PA Howard Hospital pharmacy 49 (10), 907-912, 2014 | 22 | 2014 |
| Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapy JM Backes, CA Gibson, JF Ruisinger, PM Moriarty Lipids 46, 923-929, 2011 | 20 | 2011 |
| A comparison of 25-hydroxyvitamin D serum levels among those with or without statin-associated myalgias JM Backes, BJ Barnes, JF Ruisinger, PM Moriarty Atherosclerosis 218 (1), 247-249, 2011 | 20 | 2011 |
| Important considerations for treatment with dietary supplement versus prescription niacin products JM Backes, RJ Padley, PM Moriarty Postgraduate medicine 123 (2), 70-83, 2011 | 20 | 2011 |
| Variability in potency among commercial preparations of berberine RS Funk, RK Singh, RD Winefield, SE Kandel, JF Ruisinger, PM Moriarty, ... Journal of dietary supplements 15 (3), 343-351, 2018 | 18 | 2018 |
| Statin-associated diabetes mellitus: review and clinical guide JM Backes, MD Kostoff, CA Gibson, JF Ruisinger South Med J 109 (3), 167-73, 2016 | 18 | 2016 |
